No abstract available
MeSH terms
-
Administration, Oral
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Clinical Trials, Phase II as Topic
-
Dihydrouracil Dehydrogenase (NADP)
-
Drug Combinations
-
Humans
-
Oxidoreductases / antagonists & inhibitors
-
Oxonic Acid / administration & dosage
-
Oxonic Acid / adverse effects
-
Pyridines / administration & dosage
-
Pyridines / adverse effects
-
Stomach Neoplasms / drug therapy*
-
Tegafur / administration & dosage
-
Tegafur / adverse effects
-
Treatment Outcome
Substances
-
Drug Combinations
-
Pyridines
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
Oxidoreductases
-
Dihydrouracil Dehydrogenase (NADP)